Anti-CXCL10/IP-10 Antibody (Eldelumab)
Catalog No.
F1106
Anti-CXCL10/IP-10 Antibody (Eldelumab)
Featured Products
Eldelumab (BMS-936557) is a humanized anti-CXCL10 (IP-10) monoclonal antibody (IgG1 type). Eldelumab selectively binds to CXCL10 and blocks CXCL10-induced calcium flux and cell migration. Eldelumab can be used in the study of autoimmune and autoinflammatory diseases such as rheumatoid arthritis, ulcerative colitis, and Crohn's disease.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.64 kDa
Dry ice
946414-98-8
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
MDX-1100, BMS-936557
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P02778
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
CXCL10 / IP-10
Please avoid freeze-thaw cycles.